In the frontal cortex of patients with PD, both increased and decreased ATP13A2 protein levels as compared to controls have been reported [21], whereas increased levels of ATP13A2 protein have been reported in the nigral dopaminergic and cortical pyramidal neurons of the PD patient’s brain [13]. The gene discussed is ATP13A2; the disease is Parkinson disease.